Answer
Lorlatinib can cross the blood-brain barrier, and clinical studies included people with central-nervous-system metastases. Individual suitability and response require specialist assessment.
Sources for this answer
- Lorviqua 100mg Film Coated Tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.